Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 102

Results For "Liver"

2920 News Found

DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem
Startup | September 05, 2025

DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem

Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha


iPHEX 2025: Piyush Goyal calls for deeper global collaborations to strengthen healthcare systems worldwide
Healthcare | September 05, 2025

iPHEX 2025: Piyush Goyal calls for deeper global collaborations to strengthen healthcare systems worldwide

Goyal reaffirmed the government’s commitment to facilitating market access, reducing trade barriers, and ensuring that Indian exporters remain globally competitive


Granules India and NIPER S.A.S Nagar launch CoE for sustainable pharma innovation
Sustainability | September 05, 2025

Granules India and NIPER S.A.S Nagar launch CoE for sustainable pharma innovation

It will focus on interface between API and formulation manufacturing, reducing carbon footprint in formulation production, creating intellectual property, training next-generation scientists, and setting new industry benchmarks


MedTech Expo 2025: ICMR licenses nine technologies to 17 industry partners
News | September 05, 2025

MedTech Expo 2025: ICMR licenses nine technologies to 17 industry partners

These licenses are given in areas of infectious disease diagnostics, immunodiagnostics, and vaccine development


Edwards Lifesciences launches next-gen transcatheter heart valve in India
News | September 05, 2025

Edwards Lifesciences launches next-gen transcatheter heart valve in India

Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology


AstraZeneca’s Baxdrostat proves effective in in Phase III trial for hard-to-control hypertension
Clinical Trials | September 05, 2025

AstraZeneca’s Baxdrostat proves effective in in Phase III trial for hard-to-control hypertension

The medicine was well tolerated, with no unexpected safety issue


Quotient Sciences and CPI join forces to accelerate RNA drug development
News | September 05, 2025

Quotient Sciences and CPI join forces to accelerate RNA drug development

The partnership will create a first-of-its-kind, fully integrated offering for the development of mRNA drug products


FDA expands medtronic MiniMed 780G system
Drug Approval | September 05, 2025

FDA expands medtronic MiniMed 780G system

Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes


Lupin receives FDA approval for Risperidone LAI with 180-day CGT exclusivity
Drug Approval | September 04, 2025

Lupin receives FDA approval for Risperidone LAI with 180-day CGT exclusivity

This is Lupin's first product using proprietary Nanomi's technology and has a 180-day CGT exclusivity